{"name":"Be Biopharma","slug":"be-biopharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE54YTd6U0Z6bkhSVmR3cEFEd2lESjRaQjRpZU1paTR6T1dmQjVJTFJETkd3UXNSaGdja1NQbDFocDVaZHV0M0NyRThZT2REM1RWYldvMTJQanRiYS00NzEzVTB1Njl1bEpOQ19ST0x6cmUzTlRKZ2pOZDQtNnI?oc=5","date":"2026-03-31","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2026: Lipella, IO shutter; Takeda plots 634 US job cuts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNY0stRkIza2UwMDEtY2pQN1hMQWdmdTUtN1JkTUdGWTM0QnZJY1pPaVVFLURsUzRmS0NoaDZ0dF9UTmswR1A3eTI3U3lUbl9JRzVzcUxVVDJvSEZjaHNyZ2NWX0NQMHJDMEhxU3VRODFhcjBtajdDcDF1WXp3Q2xwc0NBWnFfbXVjd3NWdHhfNVVRWkhmRTlZNjFDdzNQdE1TMVJV?oc=5","date":"2026-03-02","type":"pipeline","source":"Clarivate","summary":"Pharmas and biotechs are investing in new treatments for diseases of aging - Clarivate","headline":"Pharmas and biotechs are investing in new treatments for diseases of aging","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOOExZRFJRZ3lheFdmbzVBSmZjTFR4TkJxaGZ2TEhodlZWelVpTVZfQzFkZU1tb3dNZ3dUOTh6dXMtdXVqY1hVQ2N3MS1EMGpIMnlQd0JnYnBqMTJRM201X0x6aU9kaDR1UUFoWUhuWVZlT3g4cEk1aFdicHBGVUVPSjdwcG1Cemd5dFNGc3FBa2c?oc=5","date":"2026-02-09","type":"deal","source":"BioPharma Dive","summary":"Takeda, Iambic partner in latest pharma AI push - BioPharma Dive","headline":"Takeda, Iambic partner in latest pharma AI push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNOVF2Qm1TNExIRmZ0S3A4c3gwZVlSSTlhZHdNQ09HdmFhQlpTdFpBS19hX3VQS3pIYkV0cFBDai0wXzJRMUVDUzk0Vkd1WGJTSmRXc0lwcFZKczloUFN5WlNwbl8xTVJtWU1yM1luRk5ma3N4OWFBMXpZQ2dycEEwbg?oc=5","date":"2026-01-26","type":"pipeline","source":"Pharma Voice","summary":"Biopharma layoffs surged last year, but 2026 is a chance to turn the page - Pharma Voice","headline":"Biopharma layoffs surged last year, but 2026 is a chance to turn the page","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFBrbFY5MjJEV015dFlNOUhfUlVocG9WVmdZOThJTE5oLU0wX3lFUjdhckFMelItb05jV3JGeTBhUmlsYWE2LWZCWk5kbmF0T29BemEwZ3M3UjRxU0NWVmRsaDdvWnFOeWtKMHhoUTRWbWw1NnpT?oc=5","date":"2026-01-12","type":"deal","source":"fiercepharma.com","summary":"The top 10 biopharma M&A deals of 2025 - fiercepharma.com","headline":"The top 10 biopharma M&A deals of 2025","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-07","type":"patent","source":"CNBC","summary":"Big Pharma race to snap up biotech assets as $170 billion patent cliff looms - CNBC","headline":"Big Pharma race to snap up biotech assets as $170 billion patent cliff looms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQbGVBcl92bXpYX2ExVlRadUJZRmRleS1OMHdjVHpUTkYwZTBGdy1uM2VMVnpRNU9waUN5aUVSQXBzWkRjdUtPbGZZZUY5aXBNZHZtaXZtT09URUxWakc1dXdlV21udVJ3eTljMVgzbkdjNXRGRFVNejlFZzVBZVlGN0NuSEJfM3JGenZydkU0ckdOdWI5RE1DdnBmaGIwN3A1dXc?oc=5","date":"2025-10-23","type":"pipeline","source":"Science | AAAS","summary":"2025’s Top Employers: Innovation, AI, and policy in biotech & pharma - Science | AAAS","headline":"2025’s Top Employers: Innovation, AI, and policy in biotech & pharma - Science | AAAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNWk9DS1pHaDBhXzVxVU1kRHRwUDNTWlJobFQxbmhtVHRyRjR4ekhoTXhxZ2owSXI0Ny01RFJYZVlFaWdrZzFIUV9Vc2dId090Z19iVWtxSWtYR2JQYkdpdC1mZEVuRzh2Q2tYMFdDejg1MFp1a1lPVU84Q0kwV1d0RF9CdnBSbDJuVDdDRGlhMmhJN3R5a0EwSdIBowFBVV95cUxPcmRwRjdmMmtqUm45cXlWNVkyc3N3TXFqWXZXWDhPRklicVR0ckRKc3FFWDJwOGNPbW8tWXVWZnpaZDBEWERJVmlqTVNGVjRfdzZWYnV1Y3IyLWdCZ2ItTmt1c0ZXTlhWMVF6Y2lsOVlKbGxCcjhaTUNITkVJemJLNEM1dGdvbGhlSDBTUGxoTFM0elBGUE1XUmtkOGdRUlZ2dFJB?oc=5","date":"2025-09-19","type":"deal","source":"ETF Trends","summary":"As M&A Deals Rise, Can Biotech Pharma Break Loose? - ETF Trends","headline":"As M&A Deals Rise, Can Biotech Pharma Break Loose?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQNldYZm1qMHVPcURObHg4R1FibUF0M1lPcUkwTFlQMDVQT0FBWlBFY1NONm9ZWnU4YWgyaEh6MVZZcGt5Z25EUDhHa2hweTJZeXRtRmZGT0wtYWJEd05ZZ2J5Y2tzeXJ1bEtsMGtJcjhJWmhqb1hIRm9DdnMtSS1ETEU2Zi0tTjROclZ0a2xnU2FsOU56MVJCd0RKZUJHTk5yLUdIX2dCNC1IQ0JhdEhjcGJwYlQ2Skk3dlNBUVVLWW8wZVFUMEdaM2owUV9HOTFlYjU1dk82dWhyOHFTUWc?oc=5","date":"2025-07-24","type":"earnings","source":"Reuters","summary":"Contract research firms' strong earnings signal stabilizing biotech, pharma spending - Reuters","headline":"Contract research firms' strong earnings signal stabilizing biotech, pharma spending","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1xdGhRWEp6Y003bG9Sdnc3aXVWcFFPNnRhdlpfUE8yVkJ4cjE2RUZ0RXVKanNHeWF0QlV5QldHSXp3X0ZmaUZWazJaVWkybUVicE51UGJ5eUw4b3lFY0g5R0x1bzRmemhDM1BYb1lja1lkNGZsWG55UFF1X0o?oc=5","date":"2025-07-09","type":"trial","source":"Endpoints News","summary":"Biopharma's 20 highest-paid CEOs of 2024 with $20M+ paydays - Endpoints News","headline":"Biopharma's 20 highest-paid CEOs of 2024 with $20M+ paydays","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE91V2tzSzk2UHRKNjctSHQ5Yktxa1JORkJYZTJBTFZLVmo2UnRzYW1wX2hmQlZ4T0s0RTFNcmRMYzJVakNrWTBzYWI4TTZhSUZ2LTItZTFuY1FkS2JXdXRB?oc=5","date":"2025-05-06","type":"deal","source":"Nature","summary":"How I honed my biopharma dealmaking and business-development skills after my PhD - Nature","headline":"How I honed my biopharma dealmaking and business-development skills after my PhD","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}